Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
CNDO-109-AANK for AML in First Complete Remission (CR1)
ClinicalTrials.gov study NCT01520558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS
ClinicalTrials.gov study NCT00839982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AML Therapy With Irradiated Allogeneic Cells
ClinicalTrials.gov study NCT02105116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
ClinicalTrials.gov study NCT03793478. IPD Sharing: YES. Countries: 10. Publications: 0.
Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
ClinicalTrials.gov study NCT05569512. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00358644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ivosidenib as Post-HSCT Maintenance for AML
ClinicalTrials.gov study NCT06707493. IPD Sharing: YES. Countries: 1. Publications: 0.
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
ClinicalTrials.gov study NCT02312037. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
ClinicalTrials.gov study NCT00882102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
ClinicalTrials.gov study NCT04842604. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03315039. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00880269. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
ClinicalTrials.gov study NCT00583102. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
ClinicalTrials.gov study NCT00871689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
ClinicalTrials.gov study NCT03417154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
ClinicalTrials.gov study NCT00568633. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03723681. IPD Sharing: YES. Countries: 1. Publications: 0.
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04284787. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00808080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02177812. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.